ArticleJournal of surgical case reports2025
Isolated pulmonary metastatic disease from prostate cancer as an initial symptom in a patient following transurethral resection of the prostate for benign disease with normal histopathology.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benign prostatic hyperplasia (BPH) remains a predominant cause of acute urinary retention (AUR) in elderly males. Transurethral resection of the prostate (TURP) is the gold-standard treatment for BPH, often uncovering incidental prostate cancer (IPC). Here, we present a unique case of an 80-year-old patient with refractory AUR due to BPH who underwent TURP. Despite benign histopathology, the patient developed isolated pulmonary metastases as the initial symptom of prostate cancer (PCa) eight months postoperatively. Diagnostic evaluation revealed advanced PCa with a Gleason Score of 8 and no other metastases. The rapid progression suggests potential vascular dissemination during TURP, although evidence remains inconclusive. This case highlights the importance of diligent follow-up post-TURP to exclude occult PCa, particularly in high-risk patients. The findings also raise questions about current histopathological evaluation protocols and the need for standardized follow-up practices to improve early detection and management of advanced PCa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.